Positive Data Shows Improvement in Multiple Long-COVID Symptoms with Valacyclovir and Celecoxib Treatment

ke-size="size16">Virios Therapeutics, Inc. (Nasdaq: VIRI), a biotechnology company focused on developing antiviral therapies for chronic diseases, has announced encouraging findings from a study demonstrating the effectiveness of a combination treatment in improving multiple Long-COVID symptoms. The study specifically targeted female patients diagnosed with Long-COVID illness, also known as Post..